https://publichealth.ouhsc.edu/Departments-Centers Parent Page: Departments & Centers id: 26023 Active Page: Gary Raskobid:26282
Gary Raskob

Dean & Regents Professor

Gary E. Raskob, Ph.D.

Contact Information

Phone: (405) 271-2201

Office: Hudson College of Public Health

801 NE 13th St, Room 128

Post Office Box 26901

Oklahoma City, OK 73104

Email: Gary-Raskob@ouhsc.edu

Biography

Dr. Gary Raskob is Dean of the Hudson College of Public Health and Regents Professor of Epidemiology and Medicine at the University of Oklahoma Health Sciences Center. He is originally from Hamilton, Canada but has called Oklahoma his home for 30 years. 

Dr. Raskob is considered a leading global expert on thrombosis and venous thromboembolism (VTE). He has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology (ASH), the American College of Chest Physicians (ACCP), the American Thoracic Society (ATS), and the American Society of Clinical Oncology (ASCO).  Dr. Raskob also serves as a member of the external advisory panel on thrombosis and hemostasis for the National Heart, Lung and Blood Institute (NHLBI), and as an advisor on blood disorders to the Centers for Disease Control and Prevention (CDC) and Chair of the Steering Committee, World Thrombosis Day, International Society on Thrombosis and Haemostasis. He is author or co-author of more than 200 publications on the prevention, diagnosis and treatment of thromboembolic disease, including 19 articles in the New England Journal of Medicine. Most recently, he served as editor and provided public health content for a book authored by OU alumnus, civic leader and philanthropist Gene Rainbolt.

Dr. Raskob is the immediate past Chair of the Board of Directors for the Association of Schools and Programs of Public Health, the organization which represents more than 100 universities in the US and globally with accredited schools and programs in public health.  Dr. Raskob is active in public health service in his community; he serves as Chair of the Oklahoma City-County Board of Health, which has oversight responsibility for the health department serving the residents of Oklahoma City-County.

Education

Education:

  • PhD, Pharmaceutical Sciences, University of Oklahoma, 1999
  • MS, Clinical Epidemiology and Health Research Methodology, McMaster University, 1985
  • BS, Pharmacology, University of Toronto, 1982

Appointments

Appointments:

  • Assistant Professor, Department of Biostatistics and Epidemiology, and Department of Medicine, University of Oklahoma Health Sciences Center, 19921996
  • Associate Professor, Department of Biostatistics and Epidemiology, and Department of Medicine, University of Oklahoma Health Sciences Center, 19962000          
  • Associate Vice President for Clinical Research, University of Oklahoma Health Sciences Center, 2000–2008     
  • Professor, Department of Biostatistics and Epidemiology, and Department of Medicine, University of Oklahoma Health Sciences Center, 2000present               
  • Dean, Hudson College of Public Health, University of Oklahoma Health Sciences Center, 2002present  
  • Provost Research Award (senior faculty), 1997                    
  • Samuel Roberts Noble Foundation Presidential Professorship, 19992003
  • Chair, Steering Committee, World Thrombosis Day, International Society on Thrombosis and Haemostasis, 20132018   
  • Chair, Scientific Committee on Thrombosis and Vascular Biology, American Society of Hematology, 2014              
  • Vice Chair, Oklahoma City - County Board of Health, 2014              
  • Regents Professorship, University of Oklahoma, 2014              
  • Chair, Oklahoma City-County Board of Health, 2017present            

Teaching:

  • BSE 5153 Clinical Trials
  • PHAR 7152 Drug Study Design
  • BSE 5113 Principles of Epidemiology
  • BSE 5193 Intermediate Epidemiology
  • BSE 5033 Overview of Public Health
  • BSE 5960 Contemporary Topics in Public Health
  • Undergraduate Course HON 2973 Perspectives in Public Health
  • Undergraduate Course PHCH 2013 Introduction to Public Health
  • Undergraduate Course PHCH 3213 Health, Policy, Law and Ethics
  • Undergraduate Course PHCH 3513 Public Health and Healthcare Systems

Research

Research Interests:

  • Clinical studies to improve the diagnosis of Venous Thromboembolism (VTE)
  • Evidence-based practice guidelines for antithrombotic therapy and diagnosis of VTE
  • Treatment of Cancer-Associated Venous Thromboembolism
  • Prevention, diagnosis, and treatment of deep-vein thrombosis and pulmonary embolism
  • Translation of research evidence into practice and health policy

Publications

Link to Dr. Raskob's current publications

Select publications:

  1. Raskob, Gary (Editor). Oklahoma Pride: Working Together for the Well-being of All Oklahomans. Oklahoma City, OK: Full Circle Bookstore; 2021.
  2. Raskob, Gary; Spyropoulos, Alex; Cohen, Alexander; Weitz, Jeffrey; Ageno, Walter; Sanctis, Yoriko; Lu, Wentao; Xu, Jianfeng; Albanese, John; Sugarmann, Chiara; Weber, Traci; Lipardi, Concetta; Spiro, Theodore; Barnathan, Elliot. Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients. J Am Heart Assoc. 2021;10(5):e019459. doi:10.1161/JAHA.120.019459
  3. Wendelboe, Aaron; Campbell, Janis; Ding, Kai; Bratzler, Dale; Beckman, Michele; Reyes, Nimia; Raskob, Gary. Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma. Thromb Haemost. 2021;121(6):816-825. doi:10.1055/s-0040-1722189
  4. O’Connell, Casey; Escalante, Carmen; Goldhaber, Samuel; McBane, Robert; Connors, Jean; Raskob, Gary. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats. Oncologist. 2021;26(1):e8-e16. doi:10.1002/onco.13584
  5. Spyropoulos, Alex; Ageno, Walter; Albers, Gregory; Elliott, C.; Halperin, Jonathan; Hiatt, William; Maynard, Gregory; Steg, P.; Weitz, Jeffrey; Lu, Wentao; Spiro, Theodore; Barnathan, Elliot; Raskob, Gary. Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients. J Am Coll Cardiol. 2020;75(25):3140-3147. doi:10.1016/j.jacc.2020.04.071